Lawrence Otto Klein sold $2.4M of ORKA stock

Lawrence Otto Klein, Chief Executive Officer of Oruka Therapeutics, Inc. (ORKA), sold 25,000 shares of ORKA stock worth $2.4M, per an SEC Form 4 filed Nov 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Nov 2, 2026.

ORKA has moved +7.8% since the trade date, from $95.43 to $102.86 (Nov 6, 2026 close).